Updated on 28 March 2014
"The first three complex cases in this study highlight the advantages of the underlying Chocolate platform in creating a larger and more uniform lumen while minimizing vessel trauma," stated Dr. Andrew Holden, Director of Interventional Services at Auckland City Hospital and Associate Professor of Radiology at Auckland University School of Medicine.
"First Generation drug-coated balloons are based on Plain Old Balloon Angioplasty (POBA) technology that goes back more than 30 years. POBA is well known to induce significant vessel trauma and often requires adjunctive stenting to complete the procedure," added Dr. Eitan Konstantino, President and CEO, TriReme Medical. "The mere addition of a drug does not solve this issue. The drug coated Chocolate PTA balloon is the only product that is designed to address both the acute trauma and long term results."